According to Leadership Newspaper, The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, on Friday announced the grants of US$5.7 million to
six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.
This was contained in a press statement made available to journalists in New York by Dr. BT Slingsby, the Executive Director of the GHIT, who stated that the agency's six new investments in potential treatments for malaria, tuberculosis and Chagas disease, infections that afflict roughly one in seven of our world's population, were a definitive step forward for, and a clear exemplification of, Japanese innovation and its application to global health.
"For malaria, a disease that sickens more than 200 million people each year and kills more than 650,000, the GHIT Fund will fund four new research and development (R&D) investments.
The statement pressed further that a recently published study had revealed that the vaccine showed efficacy against severe malarial infections, making it a promising malaria vaccine candidate.
"In the initial trials in a malaria-prone region of Uganda, however, many vaccinated adult individuals failed to generate a strong immune response to the original BK-SE36" it noted.
It further said that the research team would use the new grant to test whether adding CpG, a substance known as an adjuvant, could boost the subjects' response to the vaccine, stressing that researchers agreed that a vaccine was desperately needed to check malaria's spread in the developing world, as part of a multipronged approach that includes other tools like bednets, sprays and antimalarial drugs.
We at Health Infotainment Nigeria are saying 'Good Job' GHIT... Thank You GHIT!!!
Sent from my BlackBerry wireless device from MTN
No comments:
Post a Comment
Keep staying Healthy, Informed and Entertained...
Your comments/views will be appreciated.... Thanks